Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 850.00 | 817.25 | 1.0401 | 1.0590 |
| BT-20 | Lapatinib | 10 | uM | 9 | 625.00 | 320.09 | 371.00 | 817.25 | 0.4540 | 0.1153 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 778.00 | 817.25 | 0.9520 | 0.9285 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 942.00 | 817.25 | 1.1526 | 1.2215 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 630.00 | 817.25 | 0.7709 | 0.6499 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 767.00 | 817.25 | 0.9385 | 0.9083 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 693.00 | 817.25 | 0.8480 | 0.7704 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 700.00 | 817.25 | 0.8565 | 0.7836 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 592.00 | 817.25 | 0.7244 | 0.5757 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 272.00 | 817.25 | 0.3328 | -0.1134 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 406.00 | 817.25 | 0.4968 | 0.1922 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1002.00 | 817.25 | 1.2261 | 1.3253 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 965.00 | 817.25 | 1.1808 | 1.2615 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1044.00 | 817.25 | 1.2775 | 1.3970 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 320.09 | 292.00 | 817.25 | 0.3573 | -0.0657 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 981.00 | 817.25 | 1.2004 | 1.2892 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 979.00 | 817.25 | 1.1979 | 1.2857 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 953.00 | 817.25 | 1.1661 | 1.2407 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 1068.00 | 817.25 | 1.3068 | 1.4376 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 625.00 | 320.09 | 393.00 | 817.25 | 0.4809 | 0.1639 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 942.00 | 817.25 | 1.1526 | 1.2215 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 1042.00 | 817.25 | 1.2750 | 1.3936 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 314.00 | 817.25 | 0.3842 | -0.0141 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 962.00 | 817.25 | 1.1771 | 1.2563 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 909.00 | 817.25 | 1.1123 | 1.1637 |